Caplacizumab
Veltuzumab
Abrilumab
Abituzumab
RGD-4C
Efalizumab
Etrolizumab
Volociximab
Enlimomab
Etaracizumab
Tadocizumab
Bersanlimab
Ontamalimab
Rovelizumab
Cyclo(Ala-Arg-Gly-Asp-Mamb)
BT200 sodium
RTDLDSLRTYTL
ATN-161
GSK 3008348 hydrochloride
Fradafiban